Nonsteroidal anti-inflammatory drugs during pregnancy and the initiation of lactation

Anesthesia and Analgesia

Volumn 116, Issue 5, 2013, Pages 1063-1075

  Bloor, Melanie ^a   Paech, Michael ^a  

^a KING EDWARD MEMORIAL HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CALCIUM CHANNEL BLOCKING AGENT; CELECOXIB; CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2 INHIBITOR; DICLOFENAC; FENOPROFEN; FLUFENAMIC ACID; FLURBIPROFEN; IBUPROFEN; INDOMETACIN; KETOPROFEN; KETOROLAC; LORNOXICAM; MAGNESIUM SULFATE; MEFENAMIC ACID; NAPROXEN; NIMESULIDE; NONSTEROID ANTIINFLAMMATORY AGENT; OXYTOCIN; PARACETAMOL; PARECOXIB; PETHIDINE; PIROXICAM; ROFECOXIB; SULINDAC; TENOXICAM; TOLMETIN; UNINDEXED DRUG; VALDECOXIB;

ANTIPHOSPHOLIPID SYNDROME; BIRTH DEFECT; BRAIN HEMORRHAGE; BREAST FEEDING; BREAST MILK; CLEFT LIP; CONGENITAL HEART MALFORMATION; CRYPTORCHISM; DEPRESSION; DRUG BLOOD LEVEL; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG HALF LIFE; DRUG MECHANISM; DRUG MEGADOSE; DRUG USE; DUCTUS ARTERIOSUS OBLITERATION; FERTILITY; FERTILIZATION IN VITRO; FETUS RISK; FIRST TRIMESTER PREGNANCY; HUMAN; INSTRUMENTAL DELIVERY; KIDNEY DYSFUNCTION; KIDNEY INJURY; LACTATION; LOW DRUG DOSE; METABOLIC ACIDOSIS; NECROTIZING ENTEROCOLITIS; NONHUMAN; OLIGOHYDRAMNIOS; PAIN; PATENT DUCTUS ARTERIOSUS; PREECLAMPSIA; PREGNANCY; PREMATURE LABOR; PRENATAL EXPOSURE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SECOND TRIMESTER PREGNANCY; SEDATION; SIDE EFFECT; SPONTANEOUS ABORTION; TOCOLYSIS; UNSPECIFIED SIDE EFFECT; VAGINAL DELIVERY;

ABORTION, HABITUAL; ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIPHOSPHOLIPID SYNDROME; ASPIRIN; BREAST FEEDING; CONGENITAL ABNORMALITIES; FEMALE; FERTILIZATION IN VITRO; HUMANS; INFANT; INFANT, NEWBORN; LACTATION; MILK, HUMAN; PAIN MANAGEMENT; PAIN, POSTOPERATIVE; POSTPARTUM PERIOD; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY TRIMESTER, SECOND; PREGNANCY TRIMESTER, THIRD;

EID: 84876781771     PISSN: 00032999     EISSN: 15267598     Source Type: Journal    
DOI: 10.1213/ANE.0b013e31828a4b54     Document Type: Review

References (167)

1. Glover DD, Amonkar M, Rybeck BF, Tracy TS. Prescription, over-The-counter, and herbal medicine use in a rural, obstetric population. Am J Obstet Gynecol 2003;188:1039-45
2. Temprano KK, Bandlamudi R, Moore TL. Antirheumatic drugs in pregnancy and lactation. Semin Arthritis Rheum 2005;35:112-21
3. Higby K, Xenakis EM, Pauerstein CJ. Do tocolytic agents stop preterm labor? A critical and comprehensive review of efficacy and safety. Am J Obstet Gynecol 1993;168:1247-56
4. Østensen ME, Skomsvoll JF. Anti-inflammatory pharmacotherapy during pregnancy. Expert Opin Pharmacother 2004;5:571-80
5. Committee on Drugs, American Academy of Pediatrics. The transfer of drugs and other chemicals into human milk. Pediatrics 2001;108:776-89
6. Briggs GG, Freeman RK, Yaffe SJ. Drugs in Pregnancy and Lactation. 9th ed. Philadelphia: Lippincott Williams and Wilkins, 2011
7. British Medical Association and the Royal Pharmaceutical Society of Great Britain. Prescribing in breast feeding. In: British National Formulary. 62nd ed. UK: BMJ Publishing Group, 2011
8. Cashman JN. The mechanisms of action of NSAIDs in analgesia. Drugs 1996;52 Suppl 5:13-23
9. Gan TJ. Diclofenac: An update on its mechanism of action and safety profile. Curr Med Res Opin 2010;26:1715-31
10. Maves TJ, Pechman PS, Meller ST, Gebhart GF. Ketorolac potentiates morphine antinociception during visceral nociception in the rat. Anesthesiology 1994;80:1094-101
11. Moren J, Francois T, Blanloeil Y, Pinaud M. The effects of a nonsteroidal antiinflammatory drug (ketoprofen) on morphine respiratory depression: A double-blind, randomized study in volunteers. Anesth Analg 1997;85:400-5
12. Deussen AR, Ashwood P, Martis R. Analgesia for relief of pain due to uterine cramping/involution after birth. Cochrane Database Syst Rev 2011:CD004908
13. De Oliveira GS Jr, Agarwal D, Benzon HT. Perioperative single dose ketorolac to prevent postoperative pain: A meta-Analysis of randomized trials. Anesth Analg 2012;114:424-33
14. Elia N, Lysakowski C, Tramèr MR. Does multimodal analgesia with acetaminophen, nonsteroidal antiinflammatory drugs, or selective cyclooxygenase-2 inhibitors and patientcontrolled analgesia morphine offer advantages over morphine alone? Meta-Analyses of randomized trials. Anesthesiology 2005;103:1296-304
15. Marret E, Kurdi O, Zufferey P, Bonnet F. Effects of nonsteroidal antiinflammatory drugs on patient-controlled analgesia morphine side effects: Meta-Analysis of randomized controlled trials. Anesthesiology 2005;102:1249-60
16. Maund E, McDaid C, Rice S, Wright K, Jenkins B, Woolacott N. Paracetamol and selective and non-selective non-steroidal antiinflammatory drugs for the reduction in morphine-related sideeffects after major surgery: A systematic review. Br J Anaesth 2011;106:292-7
17. Reese J, Zhao X, Ma WG, Brown N, Maziasz TJ, Dey SK. Comparative analysis of pharmacologic and/or genetic disruption of cyclooxygenase-1 and cyclooxygenase-2 function in female reproduction in mice. Endocrinology 2001;142:3198-206
18. Gaytán M, Morales C, Bellido C, Sánchez-Criado JE, Gaytán F. Non-steroidal anti-inflammatory drugs (NSAIDs) and ovulation: Lessons from morphology. Histol Histopathol 2006;21:541-56
19. Diao HL, Zhu H, Ma H, Tan HN, Cong J, Su RW, Yang ZM. Rat ovulation, implantation and decidualization are severely compromised by COX-2 inhibitors. Front Biosci 2007;12:3333-42
20. Martini AC, Vincenti LM, Santillán ME, Stutz G, Kaplan R, Ruiz RD, de Cuneo MF. Chronic administration of nonsteroidal-Antiinflammatory drugs (NSAIDS): Effects upon mouse reproductive functions. Rev Fac Cien Med Univ Nac Cordoba 2008;65:47-59
21. Stone S, Khamashta MA, Nelson-Piercy C. Nonsteroidal antiinflammatory drugs and reversible female infertility: Is there a link? Drug Saf 2002;25:545-51
22. Norman RJ, Wu R. The potential danger of COX-2 inhibitors. Fertil Steril 2004;81:493-4
23. Schisterman EF, Gaskins AJ, Whitcomb BW. Effects of lowdose aspirin in in-vitro fertilization. Curr Opin Obstet Gynecol 2009;21:275-8
24. Poustie VJ, Dodd S, Drakeley AJ. Low-dose aspirin for in vitro fertilisation. Cochrane Database Syst Rev 2007;4:CD004832
25. Akande V, Garas A, Cahill D. The effect of diclofenac and paracetamol on pregnancy and implantation rates in infertile women undergoing IVF treatment. J Obstet Gynaecol 2006;26:785-7
26. Kailasam C, Hunt LP, Ryder I, Bhakri I, Gordon UD. Safety and effectiveness of diclofenac sodium in assisted reproduction treatment: A randomized prospective double-blind study. Reprod Biomed Online 2008;16:724-9
27. Dal Prato L, Borini A. Effect of piroxicam administration before embryo transfer on IVF outcome: A randomized controlled trial. Reprod Biomed Online 2009;19:604-9
28. Vroom F, van den Berg PB, de Jong-van den Berg LT. Prescribing of NSAIDs and ASA during pregnancy; do we need to be more careful? Br J Clin Pharmacol 2008;65:275-6
29. Werler MM, Mitchell AA, Hernandez-Diaz S, Honein MA. Use of over-The-counter medications during pregnancy. Am J Obstet Gynecol 2005;193:771-7
30. Siu SS, Yeung JH, Lau TK. A study on placental transfer of diclofenac in first trimester of human pregnancy. Hum Reprod 2000;15:2423-5
31. Siu SS, Yeung JH, Lau TK. An in-vivo study on placental transfer of naproxen in early human pregnancy. Hum Reprod 2002;17:1056-9
32. Nielsen GL, Sørensen HT, Larsen H, Pedersen L. Risk of adverse birth outcome and miscarriage in pregnant users of non-steroidal anti-inflammatory drugs: Population based observational study and case-control study. BMJ 2001;322:266-70
33. Li DK, Liu L, Odouli R. Exposure to non-steroidal anti-inflammatory drugs during pregnancy and risk of miscarriage: Population based cohort study. BMJ 2003;327:368
34. Nakhai-Pour HR, Broy P, Sheehy O, Bérard A. Use of nonaspirin nonsteroidal anti-inflammatory drugs during pregnancy and the risk of spontaneous abortion. CMAJ 2011;183:1713-20
35. Ofori B, Oraichi D, Blais L, Rey E, Bérard A. Risk of congenital anomalies in pregnant users of non-steroidal anti-inflammatory drugs: A nested case-control study. Birth Defects Res B Dev Reprod Toxicol 2006;77:268-79
36. Bateman DN, McElhatton PR, Dickinson D, Wren C, Matthews JN, O'Keeffe M, Thomas SH. A case control study to examine the pharmacological factors underlying ventricular septal defects in the North of England. Eur J Clin Pharmacol 2004;60:635-41
37. Werler MM, Mitchell AA, Moore CA, Honein MA; National Birth Defects Prevention Study. Is there epidemiologic evidence to support vascular disruption as a pathogenesis of gastroschisis? Am J Med Genet A 2009;149A:1399-406
38. Cleves MA, Savell VH Jr, Raj S, Zhao W, Correa A, Werler MM, Hobbs CA; National Birth Defects Prevention Study. Maternal use of acetaminophen and nonsteroidal anti-inflammatory drugs (NSAIDs), and muscular ventricular septal defects. Birth Defects Res Part A Clin Mol Teratol 2004;70:107-13
39. van Gelder MM, Roeleveld N, Nordeng H. Exposure to nonsteroidal anti-inflammatory drugs during pregnancy and the risk of selected birth defects: A prospective cohort study. PLoS ONE 2011;6:e22174
40. Cassina M, De Santis M, Cesari E, van Eijkeren M, Berkovitch M, Eleftheriou G, Raffagnato F, Di Gianantonio E, Clementi M. First trimester diclofenac exposure and pregnancy outcome. Reprod Toxicol 2010;30:401-4
41. Ericson A, Källén BA. Nonsteroidal anti-inflammatory drugs in early pregnancy. Reprod Toxicol 2001;15:371-5
42. Collins E. Maternal and fetal effects of acetaminophen and salicylates in pregnancy. Obstet Gynecol 1981;58:57S-62S
43. Richards ID. Congenital malformations and environmental influences in pregnancy. Br J Prev Soc Med 1969;23:218-25
44. Nelson MM, Forfar JO. Associations between drugs administered during pregnancy and congenital abnormalities of the fetus. Br Med J 1971;1:523-7
45. Saxén I. Associations between oral clefts and drugs taken during pregnancy. Int J Epidemiol 1975;4:37-44
46. Werler MM, Mitchell AA, Shapiro S. The relation of aspirin use during the first trimester of pregnancy to congenital cardiac defects. N Engl J Med 1989;321:1639-42
47. Kallen BAJ, Olausson PO. Maternal drug use in early pregnancy and infant cardiovascular defect. Reprod Toxicol 2003;17:255-61
48. Slone D, Siskind V, Heinonen OP, Monson RR, Kaufman DW, Shapiro S. Aspirin and congenital malformations. Lancet 1976;1:1373-5
49. CLASP collaborative group. Low dose aspirin in pregnancy and early childhood development: Follow up of the collaborative low dose aspirin study in pregnancy. Br J Obstet Gynaecol 1995;102:861-8
50. Thorp JA, Walsh SW, Brath PC. Low-dose aspirin inhibits thromboxane, but not prostacyclin, production by human placental arteries. Am J Obstet Gynecol 1988;159:1381-4
51. Bujold E, Roberge S, Lacasse Y, Bureau M, Audibert F, Marcoux S, Forest JC, Giguère Y. Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: A meta-Analysis. Obstet Gynecol 2010;116:402-14
52. Trevedi NA. A meta-Analysis of low dose aspirin for prevention of preeclampsia. J Postgrad Med 2011;57:91-5
53. Empson M, Lassere M, Craig J, Scott J. Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant. Cochrane Database Syst Rev 2005:CD002859
54. Noble LS, Kutteh WH, Lashey N, Franklin RD, Herrada J. Antiphospholipid antibodies associated with recurrent pregnancy loss: Prospective, multicenter, controlled pilot study comparing treatment with low-molecular-weight heparin versus unfractionated heparin. Fertil Steril 2005;83:684-90
55. Stephenson MD, Ballem PJ, Tsang P, Purkiss S, Ensworth S, Houlihan E, Ensom MH. Treatment of antiphospholipid antibody syndrome (APS) in pregnancy: A randomized pilot trial comparing low molecular weight heparin to unfractionated heparin. J Obstet Gynaecol Can 2004;26:729-34
56. Zuckerman H, Reiss U, Rubinstein I. Inhibition of human premature labor by indomethacin. Obstet Gynecol 1974;44:787-92
57. King J, Flenady V, Cole S, Thornton S. Cyclo-oxygenase (COX) inhibitors for treating preterm labour. Cochrane Database Syst Rev 2005:CD001992
58. Koren G, Florescu A, Costei AM, Boskovic R, Moretti ME. Nonsteroidal antiinflammatory drugs during third trimester and the risk of premature closure of the ductus arteriosus: A meta-Analysis. Ann Pharmacother 2006;40:824-9
59. Mari G, Moise KJ Jr, Deter RL, Kirshon B, Huhta JC, Carpenter RJ Jr, Cotton DB. Doppler assessment of the pulsatility index of the middle cerebral artery during constriction of the fetal ductus arteriosus after indomethacin therapy. Am J Obstet Gynecol 1989;161:1528-31
60. Simhan HN, Caritis SN. Prevention of preterm delivery. N Engl J Med 2007;357:477-87
61. Sawdy RJ, Lye S, Fisk NM, Bennett PR. A double-blind randomized study of fetal side effects during and after the short-Term maternal administration of indomethacin, sulindac, and nimesulide for the treatment of preterm labor. Am J Obstet Gynecol 2003;188:1046-51
62. American College of Obstetricians and Gynecologists. Practice Bulletin 27: Management of preterm labor. Obstet Gynecol 2012;119:1308-17
63. Kristensen DM, Hass U, Lesné L, Lottrup G, Jacobsen PR, Desdoits-Lethimonier C, Boberg J, Petersen JH, Toppari J, Jensen TK, Brunak S, Skakkebaek NE, Nellemann C, Main KM, Jégou B, Leffers H. Intrauterine exposure to mild analgesics is a risk factor for development of male reproductive disorders in human and rat. Hum Reprod 2011;26:235-44
64. Boisen KA, Kaleva M, Main KM, Virtanen HE, Haavisto AM, Schmidt IM, Chellakooty M, Damgaard IN, Mau C, Reunanen M, Skakkebaek NE, Toppari J. Difference in prevalence of congenital cryptorchidism in infants between two Nordic countries. Lancet 2004;363:1264-9
65. vd Heijden AJ, Provoost AP, Nauta J, Grose W, Oranje WA, Wolff ED, Sauer PJ. Renal functional impairment in preterm neonates related to intrauterine indomethacin exposure. Pediatr Res 1988;24:644-8
66. Bernstein J, Werner AL, Verani R. Nonsteroidal anti-inflammatory drug fetal nephrotoxicity. Pediatr Dev Pathol 1998;1:153-6
67. Ali US, Khubchandani S, Andankar P, Parekhji S, Dubhalish V, Padhye B. Renal tubular dysgenesis associated with in utero exposure to Nimuselide. Pediatr Nephrol 2006;21:274-6
68. Boubred F, Vendemmia M, Garcia-Meric P, Buffat C, Millet V, Simeoni U. Effects of maternally administered drugs on the fetal and neonatal kidney. Drug Saf 2006;29:397-419
69. Dinchuk JE, Car BD, Focht RJ, Johnston JJ, Jaffee BD, Covington MB, Contel NR, Eng VM, Collins RJ, Czerniak PM. Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II. Nature 1995;378:406-9
70. Zhang MZ, Wang JL, Cheng HF, Harris RC, McKanna JA. Cyclooxygenase-2 in rat nephron development. Am J Physiol 1997;273:F994-1002
71. Cuzzolin L, Dal Cerè M, Fanos V. NSAID-induced nephrotoxicity from the fetus to the child. Drug Saf 2001;24:9-18
72. Peruzzi L, Gianoglio B, Porcellini MG, Coppo R. Neonatal endstage renal failure associated with maternal ingestion of cyclooxygenase-Type-1 selective inhibitor nimesulide as tocolytic. Lancet 1999;354:1615
73. Holmes RP, Stone PR. Severe oligohydramnios induced by cyclooxygenase-2 inhibitor nimesulide. Obstet Gynecol 2000;96:810-1
74. Jacqz-Aigrain E, Guillonneau M, Boissinot C, Bavoux F, Hartmann JF, Blot P. Maternal and neonatal effects of indomethacin administrated during pregnancy. Apropos of 18 cases. Arch Fr Pediatr 1993;50:307-12
75. Marpeau L, Bouillie J, Barrat J, Milliez J. Obstetrical advantages and perinatal risks of indomethacin: A report of 818 cases. Fetal Diagn Ther 1994;9:110-5
76. Cuzzolin L, Fanos V, Pinna B, di Marzio M, Perin M, Tramontozzi P, Tonetto P, Cataldi L. Postnatal renal function in preterm newborns: A role of diseases, drugs and therapeutic interventions. Pediatr Nephrol 2006;21:931-8
77. Norton ME, Merrill J, Cooper BA, Kuller JA, Clyman RI. Neonatal complications after the administration of indomethacin for preterm labor. N Engl J Med 1993;329:1602-7
78. Souter D, Harding J, McCowan L, O'Donnell C, McLeay E, Baxendale H. Antenatal indomethacin-Adverse fetal effects confirmed. Aust N Z J Obstet Gynaecol 1998;38:11-6
79. Van Marter LJ, Leviton A, Allred EN, Pagano M, Sullivan KF, Cohen A, Epstein MF. Persistent pulmonary hypertension of the newborn and smoking and aspirin and nonsteroidal antiinflammatory drug consumption during pregnancy. Pediatrics 1996;97:658-63
80. Macintyre PE, Schug SA, Scott DA, Visser EJ, Walker SM; APM:SE Working Group of the Australian and New Zealand College of Anaesthetists and Faculty of Pain Medicine. Acute Pain Management: Scientific Evidence. 3rd ed. Melbourne: Australian and New Zealand College of Anaesthestists and Faculty of Pain Medicine, 2010
81. Rumack CM, Guggenheim MA, Rumack BH, Peterson RG, Johnson ML, Braithwaite WR. Neonatal intracranial hemorrhage and maternal use of aspirin. Obstet Gynecol 1981;58:52S-6S
82. Sibai BM, Mirro R, Chesney CM, Leffler C. Low-dose aspirin in pregnancy. Obstet Gynecol 1989;74:551-7
83. Mousavy SM. Indomethacin induces hypertensive crisis in preeclampsia irrespective of prior antihypertensive drug therapy. Am J Obstet Gynecol 1991;165:1577
84. Schoenfeld A, Freedman S, Hod M, Ovadia Y. Antagonism of antihypertensive drug therapy in pregnancy by indomethacin? Am J Obstet Gynecol 1989;161:1204-5
85. Ruoff GE. The impact of nonsteroidal anti-inflammatory drugs on hypertension: Alternative analgesics for patients at risk. Clin Ther 1998;20:376-87
86. Walker JJ, Johnston J, Fairlie FM, Lloyd J, Bullingham R. A comparative study of intramuscular ketorolac and pethidine in labour pain. Eur J Obstet Gynecol Reprod Biol 1992;46:87-94
87. Slattery MM, Friel AM, Healy DG, Morrison JJ. Uterine relaxant effects of cyclooxygenase-2 inhibitors in vitro. Obstet Gynecol 2001;98:563-9
88. Bennett PN. Use of the monographs on drugs. In: Bennett PN, ed. Drugs and Human Lactation. 2nd ed. Amsterdam: Elsevier, 1996:67-74
89. Walker JJ, Johnstone J, Lloyd J, Rocha CL. The transfer of ketorolac tromethamine from maternal to foetal blood. Eur J Clin Pharmacol 1988;34:509-11
90. Greer IA, Johnston J, Tulloch I, Walker JJ. Effect of maternal ketorolac administration of platelet function in the newborn. Eur J Obstet Gynecol Reprod Biol 1988;29:257-60
91. Fenton C, Keating GM, Wagstaff AJ. Valdecoxib: A review of its use in the management of osteoarthritis, rheumatoid arthritis, dysmenorrhoea and acute pain. Drugs 2004;64:1231-61
92. Rømsing J, Møiniche S. A systematic review of COX-2 inhibitors compared with traditional NSAIDs, or different COX-2 inhibitors for post-operative pain. Acta Anaesthesiol Scand 2004;48:525-46
93. Levy G, Garrettson LK. Kinetics of salicylate elimination by newborn infants of mothers who ingested aspirin before delivery. Pediatrics 1974;53:201-10
94. Berlin CM Jr., Pascuzzi MJ, Yaffe SJ. Excretion of salicylate in human milk. Clin Pharm Ther 1980;27:245-6
95. Bailey DN, Weibert RT, Naylor AJ, Shaw RF. A study of salicylate and caffeine excretion in the breast milk of two nursing mothers. J Anal Toxicol 1982;6:64-8
96. Clark JH, Wilson WG. A 16-day-old breast-fed infant with metabolic acidosis caused by salicylate. Clin Pediatr (Phila) 1981;20:53-4
97. Berlin CM, Briggs GG. Drugs and chemicals in human milk. Semin Fetal Neonatal Med 2005;10:149-59
98. Lebedevs TH, Wojnar-Horton RE, Yapp P, Roberts MJ, Dusci LJ, Hackett LP, Ilett KF. Excretion of indomethacin in breast milk. Br J Clin Pharmacol 1991;32:751-4
99. Eeg-Olofsson O, Malmros I, Elwin CE, Steen B. Convulsions in a breast-fed infant after maternal indomethacin. Lancet 1978;2:215
100. Walter K, Dilger C. Ibuprofen in human milk. Br J Clin Pharmacol 1997;44:211-2
101. Townsend RJ, Benedetti TJ, Erickson SH, Cengiz C, Gillespie WR, Gschwend J, Albert KS. Excretion of ibuprofen into breast milk. Am J Obstet Gynecol 1984;149:184-6
102. Weibert RT, Townsend RJ, Kaiser DG, Naylor AJ. Lack of ibuprofen secretion into human milk. Clin Pharm 1982;1:457-8
103. Cox SR, Forbes KK. Excretion of flurbiprofen into breast milk. Pharmacotherapy 1987;7:211-5
104. Jacqz-Aigrain E, Serreau R, Boissinot C, Popon M, Sobel A, Michel J, Sibony O. Excretion of ketoprofen and nalbuphine in human milk during treatment of maternal pain after delivery. Ther Drug Monit 2007;29:815-8
105. Rubin A, Chernish SM, Crabtree R, Gruber CM, Helleberg L, Rodda BE, Warrick P, Wolen RL, Ridolfo AS. A profile of the physiological disposition and gastro-intestinal effects of fenoprofen in man. Curr Med Res Opin 1974;2:529-44
106. Todd PA, Sorkin EM. Diclofenac sodium. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy. Drugs 1988;35:244-85
107. Jamali F, Stevens DR. Naproxen excretion in milk and its uptake by the infant. Drug Intell Clin Pharm 1983;17:910-1
108. Ostensen M. Piroxicam in human breast milk. Eur J Clin Pharmacol 1983;25:829-30
109. Sagraves R, Waller ES, Goehrs HR. Tolmetin in breast milk. Drug Intell Clin Pharm 1985;19:55-6
110. Buchanan RA, Eaton CJ, Koeff ST, Kinkel AW. The breast milk excretion on flufenamic acid. Curr Ther Res Clin Exp 1969;11:533-8
111. Wischnik A, Manth SM, Lloyd J, Bullingham R, Thompson JS. The excretion of ketorolac tromethamine into breast milk after multiple oral dosing. Eur J Clin Pharmacol 1989;36:521-4
112. Hale TW, McDonald R, Boger J. Transfer of celecoxib into human milk. J Hum Lact 2004;20:397-403
113. Gardiner SJ, Doogue MP, Zhang M, Begg EJ. Quantification of infant exposure to celecoxib through breast milk. Br J Clin Pharmacol 2006;61:101-4
114. Knoppert DC, Stempak D, Baruchel S, Koren G. Celecoxib in human milk: A case report. Pharmacotherapy 2003;23:97-100
115. Lie HKH, Turner SC. Early experience with the use of celecoxib in child and adolescent population. J Pharmacy Prac Res 2002;32:27-31
116. Paech MJ, Salman S, Ilett KF, O'Halloran SJ, Muchatuta NA. Transfer of parecoxib and its primary active metabolite valdecoxib via transitional breastmilk following intravenous parecoxib use after cesarean delivery: A comparison of naive pooled data analysis and nonlinear mixed-effects modeling. Anesth Analg 2012;114:837-44
117. Dodd JM, Hedayati H, Pearce E, Hotham N, Crowther CA. Rectal analgesia for the relief of perineal pain after childbirth: A randomised controlled trial of diclofenac suppositories. BJOG 2004;111:1059-64
118. Searles JA, Pring DW. Effective analgesia following perineal injury during childbirth: A placebo controlled trial of prophylactic rectal diclofenac. Br J Obstet Gynaecol 1998;105:627-31
119. Harrison RF, Brennan M. Comparison of two formulations of lignocaine spray with mefenamic acid in the relief of post-episiotomy pain: A placebo-controlled study. Curr Med Res Opin 1987;10:375-9
120. Yeh YC, Chen SY, Lin CJ, Yeh HM, Sun WZ. Differential analgesic effect of tenoxicam on post-cesarean uterine cramping pain between primiparous and multiparous women. J Formos Med Assoc 2005;104:647-51
121. Huang YC, Tsai SK, Huang CH, Wang MH, Lin PL, Chen LK, Lin CJ, Sun WZ. Intravenous tenoxicam reduces uterine cramps after Cesarean delivery. Can J Anaesth 2002;49:384-7
122. Heydayati H, Parsons J, Crowther CA. Rectal analgesia for pain from perineal trauma following childbirth. Cochrane Database Syst Rev 2003:CD003931
123. Peter EA, Janssen PA, Grange CS, Douglas MJ. Ibuprofen versus acetaminophen with codeine for the relief of perineal pain after childbirth: A randomized controlled trial. CMAJ 2001;165:1203-9
124. Lim SS, Tan PC, Sockalingam JK, Omar SZ. Oral celecoxib versus oral diclofenac for post-perineal repair analgesia after spontaneous vaginal birth: A randomised trial. Aust N Z J Obstet Gynaecol 2008;48:71-7
125. Bloomfield SS, Mitchell J, Cissell GB, Barden TP, Yee JP. Ketorolac versus aspirin for postpartum uterine pain. Pharmacotherapy 1986;6:247-52
126. Nauta M, Landsmeer ML, Koren G. Codeine-Acetaminophen versus nonsteroidal anti-inflammatory drugs in the treatment of post-Abdominal surgery pain: A systematic review of randomized trials. Am J Surg 2009;198:256-61
127. Gin T, Kan AF, Lam KK, O'Meara ME. Analgesia after caesarean section with intramuscular ketorolac or pethidine. Anaesth Intensive Care 1993;21:420-3
128. Kantor T, Cavaliere MB, Hopper M, Roepke S. A double-blind parallel comparison of ketoprofen, codeine, and placebo in patients with moderate to severe postpartum pain. J Clin Pharmacol 1984;24:228-34
129. Rorarius MG, Suominen P, Baer GA, Romppanen O, Tuimala R. Diclofenac and ketoprofen for pain treatment after elective caesarean section. Br J Anaesth 1993;70:293-7
130. Sammour RN, Ohel G, Cohen M, Gonen R. Oral naproxen versus oral tramadol for analgesia after cesarean delivery. Int J Gynaecol Obstet 2011;113:144-7
131. Sun HL, Wu CC, Lin MS, Chang CF, Mok MS. Combination of low-dose epidural morphine and intramuscular diclofenac sodium in postcesarean analgesia. Anesth Analg 1992;75:64-8
132. Bozkurt N, Kurdoglu M, Kurdoglu Z, Kutlusoy F, Biberoglu K. Postoperative pain control after cesarean section: Can diclofenac sodium be used instead of meperidine? J Matern Fetal Neonatal Med 2009;22:1144-50
133. Lowder JL, Shackelford DP, Holbert D, Beste TM. A randomized, controlled trial to compare ketorolac tromethamine versus placebo after cesarean section to reduce pain and narcotic usage. Am J Obstet Gynecol 2003;189:1559-62
134. Elhakim M, Nafie M. I.v. tenoxicam for analgesia during caesarean section. Br J Anaesth 1995;74:643-6
135. Sia AT, Thomas E, Chong JL, Loo CC. Combination of suppository diclofenac and intravenous morphine infusion in post-caesarean section pain relief-A step towards balanced analgesia? Singapore Med J 1997;38:68-70
136. El-Tahan MR, Warda OM, Yasseen AM, Attallah MM, Matter MK. A randomized study of the effects of preoperative ketorolac on general anaesthesia for caesarean section. Int J Obstet Anesth 2007;16:214-20
137. Luthman J, Kay NH, White JB. The morphine sparing effect of diclofenac sodium following caesarean section under spinal anaesthesia. Int J Obstet Anesth 1994;3:82-6
138. Wilder-Smith CH, Hill L, Dyer RA, Torr G, Coetzee E. Postoperative sensitization and pain after cesarean delivery and the effects of single im doses of tramadol and diclofenac alone and in combination. Anesth Analg 2003;97:526-33
139. Belzarena SD. Evaluation of intravenous tenoxicam for postoperative cesarean delivery pain relief. Preliminary report. Reg Anesth 1994;19:408-11
140. Surakarn J, Tannirandorn Y. Intramuscular diclofenac for analgesia after cesarean delivery: A randomized controlled trial. J Med Assoc Thai 2009;92:733-7
141. Dahl V, Hagen IE, Sveen AM, Norseng H, Koss KS, Steen T. High-dose diclofenac for postoperative analgesia after elective caesarean section in regional anaesthesia. Int J Obstet Anesth 2002;11:91-4
142. Olofsson CI, Legeby MH, Nygårds EB, Ostman KM. Diclofenac in the treatment of pain after caesarean delivery. An opioid-saving strategy. Eur J Obstet Gynecol Reprod Biol 2000;88:143-6
143. Munishankar B, Fettes P, Moore C, McLeod GA. A doubleblind randomised controlled trial of paracetamol, diclofenac or the combination for pain relief after caesarean section. Int J Obstet Anesth 2008;17:9-14
144. Siddik SM, Aouad MT, Jalbout MI, Rizk LB, Kamar GH, Baraka AS. Diclofenac and/or propacetamol for postoperative pain management after cesarean delivery in patients receiving patient controlled analgesia morphine. Reg Anesth Pain Med 2001;26:310-5
145. Wong JO, Tan TD, Cheu NW, Wang YR, Liao CH, Chuang FH, Watts MP. Comparison of the efficacy of parecoxib versus ketorolac combined with morphine on patient-controlled analgesia for post-cesarean delivery pain management. Acta Anaesthesiol Taiwan 2010;48:174-7
146. Fong WP, Yang LC, Wu JI, Chen HS, Tan PH. Does celecoxib have pre-emptive analgesic effect after Caesarean section surgery? Br J Anaesth 2008;100:861-2
147. Alhashemi JA, Alotaibi QA, Mashaat MS, Kaid TM, Mujallid RH, Kaki AM. Intravenous acetaminophen vs oral ibuprofen in combination with morphine PCIA after Cesarean delivery. Can J Anaesth 2006;53:1200-6
148. Zohar E, Shapiro A, Eidinov A, Fishman A, Fredman B. Postcesarean analgesia: The efficacy of bupivacaine wound instillation with and without supplemental diclofenac. J Clin Anesth 2006;18:415-21
149. Tzeng JI, Mok MS. Combination of intramuscular Ketorolac and low dose epidural morphine for the relief of post-caesarean pain. Ann Acad Med Singap 1994;23:10-3
150. Sun HL, Wu CC, Lin MS, Chang CF. Effects of epidural morphine and intramuscular diclofenac combination in postcesarean analgesia: A dose-range study. Anesth Analg 1993;76: 284-8
151. Pavy TJ, Gambling DR, Merrick PM, Douglas MJ. Rectal indomethacin potentiates spinal morphine analgesia after caesarean delivery. Anaesth Intensive Care 1995;23:555-9
152. Dennis AR, Leeson-Payne CG, Hobbs GJ. Analgesia after caesarean section. The use of rectal diclofenac as an adjunct to spinal morphine. Anaesthesia 1995;50:297-9
153. Cohen SE, Desai JB, Ratner EF, Riley ET, Halpern J. Ketorolac and spinal morphine for postcesarean analgesia. Int J Obstet Anesth 1996;5:14-8
154. Carvalho B, Chu L, Fuller A, Cohen SE, Riley ET. Valdecoxib for postoperative pain management after cesarean delivery: A randomized, double-blind, placebo-controlled study. Anesth Analg 2006;103:664-70
155. Lee LH, Irwin MG, Lim J, Wong CK. The effect of celecoxib on intrathecal morphine-induced pruritus in patients undergoing Caesarean section. Anaesthesia 2004;59:876-80
156. Lim NL, Lo WK, Chong JL, Pan AX. Single dose diclofenac suppository reduces post-Cesarean PCEA requirements. Can J Anaesth 2001;48:383-6
157. Pavy TJ, Paech MJ, Evans SF. The effect of intravenous ketorolac on opioid requirement and pain after cesarean delivery. Anesth Analg 2001;92:1010-4
158. Angle PJ, Halpern SH, Leighton BL, Szalai JP, Gnanendran K, Kronberg JE. A randomized controlled trial examining the effect of naproxen on analgesia during the second day after cesarean delivery. Anesth Analg 2002;95:741-5
159. Kimura M, Okamoto T, Tsukagoshi H, Sato J, Saito S. Effect of flurbiprofen, metoclopramide and droperidol for nausea and emesis during cesarean section under spinal anesthesia. J Anesth 2011;25:692-7
160. van Ammers PM, Moore PJ, Sacho H. Necrotising fasciitis after caesarean section-Association with non-steroidal antiinflammatory drugs. A report of 3 cases. S Afr Med J 1991; 80:203-4
161. Solberg CO. Influence of phenylbutazone on the phagocytic and bactericidal activities of neutrophil granulocytes. Acta Pathol Microbiol Scand B Microbiol Immunol 1974;82: 258-62
162. Carvalho B, Clark DJ, Yeomans DC, Angst MS. Continuous subcutaneous instillation of bupivacaine compared to saline reduces interleukin 10 and increases substance P in surgical wounds after cesarean delivery. Anesth Analg 2010;111:1452-9
163. Rackelboom T, Le Strat S, Silvera S, Schmitz T, Bassot A, Goffinet F, Ozier Y, Beaussier M, Mignon A. Improving continuous wound infusion effectiveness for postoperative analgesia after cesarean delivery: A randomized controlled trial. Obstet Gynecol 2010;116:893-900
164. Lavand'homme PM, Roelants F, Waterloos H, De Kock MF. Postoperative analgesic effects of continuous wound infiltration with diclofenac after elective cesarean delivery. Anesthesiology 2007;106:1220-5
165. Du D, Eisenach JC, Ririe DG, Tong C. The antinociceptive effects of spinal cyclooxygenase inhibitors on uterine cervical distension. Brain Res 2004;1024:130-6
166. Zhu X, Conklin DR, Eisenach JC. Preoperative inhibition of cyclooxygenase-1 in the spinal cord reduces postoperative pain. Anesth Analg 2005;100:1390-3
167. Eisenach JC, Curry R, Rauck R, Pan P, Yaksh TL. Role of spinal cyclooxygenase in human postoperative and chronic pain. Anesthesiology 2010;112:1225-33